glutathione als - an overview Frontiers | Emerging Evidence Highlighting
Description
They follow dosing charts to the letter
Most evidence for BPC-157s efficacy and safety comes from animal studies, with limited human clinical data available
But adding BPC-157 was a noticeable upgrade
[6] Glutathione deficiency has been linked to a number of disease states in these tissues and cell types
doi: 10.1177/0192623308329476
